公司簡介
- 股票程式碼
- 068270
- ISIN程式碼
- KR7068270008
- 貨幣
- Korean Won (KRW)
- IPO日期
- 2005-07-19

Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gast...